Trends in Systemic Inflammatory Reaction (SIR) during Paclitaxel and Carboplatin Chemotherapy in Women Suffering from Epithelial Ovarian Cancer.
Michal MlekoElzbieta PlutaKazimierz PitynskiMaciej BodzekAndrzej KałamackiDorota KiprianTomasz BanaśPublished in: Cancers (2023)
During first-line adjuvant chemotherapy in women with EOC, a decrease in SIR is confirmed.